Astellas Pharma Stock Today

ALPMY Stock  USD 10.94  0.12  1.08%   

Performance

0 of 100

 
Low
 
High
Very Weak

Odds Of Distress

Less than 9

 
100  
 
Zero
Low
Astellas Pharma is trading at 10.94 as of the 28th of March 2024; that is -1.08 percent decrease since the beginning of the trading day. The stock's open price was 11.06. Astellas Pharma has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. Equity ratings for Astellas Pharma are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 27th of February 2024 and ending today, the 28th of March 2024. Click here to learn more.
Astellas Pharma Inc. engages in the manufacture, marketing, import, and export of pharmaceuticals worldwide. Astellas Pharma Inc. was founded in 1923 and is headquartered in Tokyo, Japan. ASTELLAS PHARMA operates under Drug ManufacturersGeneral classification in the United States and is traded on OTC Exchange. The company has 1.83 B outstanding shares. More on Astellas Pharma

Moving together with Astellas Pink Sheet

  0.85RHHBF Roche Holding AGPairCorr
  0.86RHHBY Roche HoldingPairCorr
  0.84RHHVF Roche Holding AGPairCorr

Moving against Astellas Pink Sheet

  0.87LLY Eli Lilly And Sell-off TrendPairCorr
  0.69MRK Merck Company Fiscal Quarter End 31st of March 2024 PairCorr
  0.67PIFMF PT Indofood SuksesPairCorr
  0.66C Citigroup Aggressive PushPairCorr
Follow Valuation Odds of Bankruptcy
Check how we calculate scores

Astellas Pink Sheet Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Astellas Pharma's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Astellas Pharma or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
CEOYoshihiko Hatanaka
Business ConcentrationDrug Manufacturers—General, Healthcare (View all Sectors)
Astellas Pharma [ALPMY] is a Pink Sheet which is traded between brokers over the counter. The company currently falls under 'Large-Cap' category with a current market capitalization of 26.53 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Astellas Pharma's market, we take the total number of its shares issued and multiply it by Astellas Pharma's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Astellas Pharma classifies itself under Healthcare sector and is part of Drug Manufacturers—General industry. The entity has 1.83 B outstanding shares. Astellas Pharma has accumulated about 336.76 B in cash with 257.44 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 184.77, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Astellas Pharma Probability Of Bankruptcy
Ownership Allocation
Astellas Pharma retains a total of 1.83 Billion outstanding shares. Almost 100.0 percent of Astellas Pharma outstanding shares are held by general public with 0.03 % by other corporate entities. Note that regardless of who owns the company, if the true value of the entity is less than the market is willing to pay for it, you may not be able to generate positive returns over time.
Check Astellas Ownership Details

Astellas Stock Price Odds Analysis

Based on a normal probability distribution, the odds of Astellas Pharma jumping above the current price in 90 days from now is about 77.81%. The Astellas Pharma probability density function shows the probability of Astellas Pharma pink sheet to fall within a particular range of prices over 90 days. Assuming the 90 days horizon Astellas Pharma has a beta of 0.2985. This suggests as returns on the market go up, Astellas Pharma average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Astellas Pharma will be expected to be much smaller as well. Additionally, astellas Pharma has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming NYSE Composite.
  Odds Below 10.94HorizonTargetOdds Above 10.94
21.98%90 days
 10.94 
77.81%
Based on a normal probability distribution, the odds of Astellas Pharma to move above the current price in 90 days from now is about 77.81 (This Astellas Pharma probability density function shows the probability of Astellas Pink Sheet to fall within a particular range of prices over 90 days) .

Astellas Pharma Risk Profiles

Investors will always prefer to have the highest possible return on investment while minimizing volatility. Astellas Pharma market risk premium is the additional return an investor will receive from holding Astellas Pharma long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Astellas Pharma. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Astellas Pharma's alpha and beta are two of the key measurements used to evaluate Astellas Pharma's performance over the market, the standard measures of volatility play an important role as well.

Astellas Stock Against Markets

Picking the right benchmark for Astellas Pharma pink sheet is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Astellas Pharma pink sheet price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Astellas Pharma is critical whether you are bullish or bearish towards Astellas Pharma at a given time. Please also check how Astellas Pharma's historical prices are related to one of the top price index indicators.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Astellas Pharma without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Equity Search Now

   

Equity Search

Search for actively traded equities including funds and ETFs from over 30 global markets
All  Next Launch Module

Astellas Pharma Corporate Directors

Astellas Pharma corporate directors refer to members of an Astellas Pharma board of directors. The board of directors generally takes responsibility for the Astellas Pharma's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Astellas Pharma's board members must vote for the resolution. The Astellas Pharma board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.
Yutaka KaseIndependent DirectorProfile
Hironobu YasudaIndependent DirectorProfile
Naoki OkamuraExecutive Officer, Director of Business PlanningProfile
Eisuke NozawaExecutive Officer, Director of Pharmaceutical AffairsProfile

How to buy Astellas Pink Sheet?

Before investing in Astellas Pharma, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Astellas Pharma. To buy Astellas Pharma stock, you can follow these steps:
  • Choose a brokerage firm: You need to select a brokerage firm to buy shares of Astellas Pharma. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
  • Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
  • Fund your account: You will need to deposit funds into your brokerage account to purchase Astellas Pharma stock. You can do this by transferring funds from your bank account or other investment accounts.
  • Place your order: Once you have located Astellas Pharma stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
  • Monitor your investment: After you have purchased Astellas Pharma stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Astellas Pharma, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments.

Already Invested in Astellas Pharma?

The danger of trading Astellas Pharma is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Astellas Pharma is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Astellas Pharma. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Astellas Pharma is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Astellas Pharma. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population.
You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.

Complementary Tools for Astellas Pink Sheet analysis

When running Astellas Pharma's price analysis, check to measure Astellas Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Astellas Pharma is operating at the current time. Most of Astellas Pharma's value examination focuses on studying past and present price action to predict the probability of Astellas Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Astellas Pharma's price. Additionally, you may evaluate how the addition of Astellas Pharma to your portfolios can decrease your overall portfolio volatility.
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Stocks Directory
Find actively traded stocks across global markets
Equity Valuation
Check real value of public entities based on technical and fundamental data
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Please note, there is a significant difference between Astellas Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Astellas Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Astellas Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.